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Summary 
Autism spectrum disorders (ASDs) are neurodevelopmental disorders with a strong genetic aetiology. Since 
mutations in human SHANK genes have been found in patients with autism, genetic mouse models are 
employed for a mechanistic understanding of ASDs and the development of therapeutic strategies. In sharp 
contrast to all studies so far on the function of SHANK proteins, we observe enhanced synaptic plasticity in 
Shank2-/- mice, under various conditions in vitro and in vivo. Reproducing and extending previous results, we 
here present a plausible mechanistic explanation for the mutants' increased capacity for long-term 
potentiation (LTP) by describing a synaptic maturation deficit in Shank2-/- mice. 
 
Introduction 
The activity-dependent formation and remodelling of synaptic connections is pivotal to adaptive neural circuit 
function. Dysregulation of these processes is considered a prime cause of neurodevelopmental diseases 
such as autism spectrum disorders (ASDs) (Ebert and Greenberg, 2013). The list of mutations associated 
with ASDs and the number of mouse models is growing rapidly, yet understanding the connection between 
genetic mutation, synaptic defects, and disease phenotypes remains a challenge. Mutations in SHANK 
genes occur in autistic patients (Durand et al., 2007; Berkel et al., 2010; Sato et al., 2012) and Shank mutant 
mice reproduce several autism-related phenotypes (Bozdagi et al., 2010; Peça et al., 2011; Wang et al., 
2011; Schmeisser et al., 2012; Won et al., 2012; Lee et al., 2015; Peter et al., 2016). SHANKs (short for SH3 
and multiple ankyrin repeat domains protein, also referred to as ProSAPs) are scaffold proteins in the 
postsynaptic density of mammalian excitatory synapses that interact with numerous synaptic proteins 
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(Monteiro and Feng, 2017). Recent reports have made a strong case for NMDA receptor hypofunction and/or 
defective long-term potentiation as a cause for disease-relevant behavioural phenotypes in Shank2 and 
Shank3 mutant mice (Won et al., 2012; Lee et al., 2015; Peter et al., 2016) and Shank3 (Bozdagi et al., 
2010; Peça et al., 2011; Kouser et al., 2013) and it has even been suggested that pharmacological 
upregulation of LTP can be used to reverse the phenotype (Won et al., 2012; Bozdagi, Tavassoli and 
Buxbaum, 2013). In sharp contrast to all other studies on the function of SHANK proteins we observe an 
enhancement of synaptic plasticity in Shank2-/- mice (Schmeisser et al., 2012). Here, we report robustly 
increased LTP in vitro and also following in vivo induction of LTP in Shank2-/- mice. Moreover, we find that 
Shank2-/- mice suffer from deficient synaptic maturation, suggesting a mechanistic explanation for their 
increased LTP capacity. This calls for further investigations into how autism-associated phenotypes reflect 
alterations in synaptic maturation and stability before we should attempt to pharmacologically increase LTP 
in autism therapies. 
 
Results and Discussion 
Motivated by methodological differences between our previous findings (Schmeisser et al., 2012) and a 
parallel study (Won et al., 2012), that reported increased (Schmeisser et al., 2012) versus decreased LTP 
(Won et al., 2012), respectively, in genetically similar Shank2-/- mice, we first investigated whether 
differences in slice storage, recording temperature, and animal age might account for the discrepancy in the 
expression of LTP. To this end, we reproduced a number of conditions from Won et al. (2012), i.e. slices were 
stored in an ACSF/oxygenated air (Haas-type) interface chamber instead of submerged in ACSF, animal age 
was 8-9 instead of 3-4 weeks, and recordings were performed at elevated instead of room temperature. 
Hippocampal slices from Shank2-/- mice were then subjected to the common LTP induction protocol (see 
Methods for details). In our hands, also in these conditions, Shank2-/- mice showed markedly higher LTP than 
wild-type controls (Figure 1A). Slice storage seemed to affect different electrophysiological phenotypes to 
various degrees, however. While storing slices submerged in ACSF versus a Haas-type interface chamber 
had no effect on the expression of LTP (Figure 1B) or basal synaptic transmission (Figure 1C), it did affect 
the observed AMPA/NMDA receptor ratios (Figure 1D). 
In light of these results and reports on substantial changes in synaptic spine morphology following brain slice 
preparation (Kirov, Sorra and Harris, 1999), we reasoned that an in vitro examination of Shank2-/- 
phenotypes might be problematic, given that SHANK2 has a well-described role in synaptogenesis and the 
regulation of structural dynamics in dendritic spines (MacGillavry et al., 2016). In particular we wondered 
whether the decreased basal synaptic transmission and increased LTP we consistently observed in Shank2-/- 
mice might be secondary to slicing-induced synaptic remodelling. This motivated us to examine synaptic 
transmission and LTP in vivo. Most rodent in vivo LTP studies have been performed in rats rather than mice, 
however, and not all protocols that generate LTP in brain slices consistently generate lasting synaptic 
plasticity in vivo, possibly due to differences in neural dynamics and neuromodulatory tone in the intact brain. 
Using recently established experimental procedures (Kemp and Manahan-Vaughan, 2008) (see Methods for 
details), we compared Shank2-/- and wild-type mice with regard to their capacity to express electrically 
induced LTP in vivo. We tested different induction protocols, eliciting both short- and long-lasting forms of 
.CC-BY-NC-ND 4.0 International licensenot peer-reviewed) is the author/funder. It is made available under a
The copyright holder for this preprint (which was. http://dx.doi.org/10.1101/193078doi: bioRxiv preprint first posted online Sep. 29, 2017; 
 3 
LTP (Kemp and Manahan-Vaughan, 2008). Both forms of LTP could be elicited in Shank2-/- mice and 
wildtype controls (Figure 2A, B), validating that synapses without SHANK2 can express LTP, as our data 
from acute slices suggest. For long-lasting LTP, the potentiation in Shank2-/- mice significantly exceeded that 
of wild-type controls (Figure 2A). Further corroborating our in vitro results, basal synaptic transmission was 
significantly decreased in Shank2-/- mice versus wildtype controls when assessed in awake, behaving 
animals (Figure 2C). In summary, we observe enhanced LTP and decreased basal synaptic transmission in 
Shank2-/- mice under a range of different conditions both in vitro and in vivo. 
How can we consolidate the discrepancy between reduced synaptic transmission and increased LTP? Is 
there a mechanistic explanation linking these two findings? In Shank3-/- mice, reduced LTP has been 
associated with NMDA as well as AMPA receptor hypofunction (Wang et al., 2011; Kouser et al., 2013). Both 
mechanisms seem plausible, since hippocampal CA1 LTP is dependent on both NMDA and AMPA receptors 
in its induction and expression, respectively (Nicoll, 2017). Shank2-/- mice show reduced AMPA receptor 
dependent basal synaptic transmission (Figure 1C), and, in certain conditions, a reduction in AMPA/NMDA 
receptor ratios (Figure 1D). We thus set out to test whether synapses lacking SHANK2 might possess fewer 
AMPA receptors or be functionally silent (i.e. lack them altogether), which would render these synapses 
salient substrates for the expression of LTP. Indeed, minimal stimulation revealed markedly higher failure 
rates in Shank2-/- mice than wild-type controls at hyperpolarized potentials (-60 mV, when only AMPA 
receptor containing synapses contribute to EPSCs) compared to depolarized potentials (+40 mV, when 
synapses lacking AMPA but possessing NMDA receptors can also pass currents) (Figure 3A). Given that the 
apparent synaptic potency was not different between genotypes (Figure 3B), this suggests that the reduced 
AMPA/NMDA receptor ratios (Figure 3C) are a direct consequence of an increased fraction of silent 
synapses in Shank2-/- mice (Figure 3D). At the same time, these silent synapses might provide the structural 
framework that facilitates the expression of LTP in Shank2-/- mice.  
A similar excess of silent synapses has been described in mice lacking Sapap3 (Wan, Feng and Calakos, 
2011), a GKAP family protein that directly interacts with SHANKs (Boeckers et al., 1999; Naisbitt et al., 1999; 
Yao et al., 1999) and whose absence in mice causes obsessive-compulsive behavioural traits (Welch et al., 
2007) – which are also typical in autistic individuals. Likewise, FMR1-/- mice, which model the autism-related 
Fragile X syndrome, show altered plasticity and synapse maturation in the barrel cortex (Harlow et al., 2010). 
In another mouse model for intellectual disability (SYNGAP1 haploinsufficiency) hippocampal synapses are 
unsilenced prematurely, adversely impacting learning and memory in the adult animal (Rumbaugh et al., 
2006; Clement et al., 2012). These and the present study draw a picture of synapse maturation as a tightly 
controlled process, the dysregulation of which seems of relevance for a range of neurodevelopmental 
disorders; this process must therefore be investigated further in future studies, in particular with regard to 
how it can be influenced by therapeutic approaches for the potential treatment of autism and related 
disorders. 
In summary, we consistently observe increased LTP in hippocampal Schaffer collateral-CA1 synapses of 
Shank2-/- mice in vitro, as well as in awake behaving animals. We have uncovered a developmental synapse 
phenotype that could link the phenomena of decreased synaptic transmission and increased LTP in Shank2-/- 
mice. These data add weight – and mechanistic insight – to our initial conclusion that SHANK2 loss of 
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function results in enhanced synaptic plasticity, highlighting the necessity to caution against generalizing 
therapeutic approaches that rely on boosting LTP as a strategy to treat ASD phenotypes. 
 
Methods 
Shank2–/– mice were bred in a C57BL/6J background with a heterozygous breeding protocol. The study was 
carried out in accordance with the European Communities Council Directive of September 22, 2010 
(2010/63/EU) for care of laboratory animals and after approval of the local ethics and/or animal welfare 
committees (Berlin animal experiment authorities and the animal welfare committee of the Charité Berlin (File 
reference: T100/03) and Landesamt für Naturschutz, Verbraucherschutz und Umweltschutz, Nordrhein 
Westfalen, respectively). Wild-type littermates were used as a control throughout and experimenters were 
blind to the genotype of the tested animals for data collection and analysis.  
Hippocampal brain slices were prepared from animals of both sexes as described(Schmeisser* et al., 2012). 
Briefly, mice were anesthetized with isoflurane and decapitated. Brains were rapidly removed and transferred 
to ice-cold ACSF slicing solution. Slicing ACSF contained (in mM): 87 NaCl, 26 NaHCO3, 50 sucrose, 25 
glucose, 3 MgCl2, 2.5 KCl, 1.25 NaH2PO4, 0.5 CaCl2. Recording ACSF contained (in mM): 119 NaCl, 26 
NaHCO3, 10 glucose, 2.5 KCl, 2.5 CaCl2, 1.3 MgCl2, 1 NaH2PO4. All ACSF was equilibrated with carbogen 
(95% O2, 5% CO2). Tissue blocks containing the hippocampus were mounted on a Vibratome (Leica 
VT1200) and cut into horizontal slices of 300 μm. For submerged slice storage (used for minimal stimulation 
experiments), slices were – after preparation – kept submerged in ACSF at 34°C for 30 min, then slowly 
cooled to room temperature where they were left to recover for at least 30 min up to 5 hours. Recordings 
were performed in slices submerged in ACSF and at room temperature. For a subset of experiments (Figure 
1), we reproduced a range of storage and recording conditions from Won et al.(Won et al., 2012): 
Immediately after preparation, slices were transferred to in an ACSF/oxygenated air interface chamber and 
allowed there to recover until recording, for at least one and at most five hours. Recordings were performed 
in a submerged recording chamber, storage and recording temperature for these experiments was 34°C. 
Mouse age for in vitro experiments was 8-9 weeks for experiments shown in Figure 1A and D, and 3-4 
weeks for experiments in figure 3. For the remaining in vitro experiments (Figure 1B, C), mouse age is 
indicated in the figure legend. 
For all in vitro experiments, data was recorded with an Axopatch 700A Amplifier, digitized at 5 kHz, filtered at 
2 kHz and recorded in IGOR Pro 4.0. Evoked postsynaptic responses were induced by stimulating Schaffer 
collaterals in CA1 stratum radiatum. Field excitatory postsynaptic potentials (fEPSPs) were recorded in 
stratum radiatum. fEPSP rising slopes were fitted to 20 to 80% of the fEPSP amplitude. LTP was induced by 
a single tetanus of 100 pulses at 100 Hz. For whole-cell patch-clamp recordings, pipettes had resistances of 
2–3 MΩ. Liquid junction potential was not corrected. Series resistance (not compensated) was constantly 
monitored and was not allowed to increase beyond 22 MΩ or change by more than 20 % during the 
experiment. Compound EPSCs were recorded at –60 and +40 mV with a cesium-based intracellular 
recording solution containing (in mM) 145 CsCl, 10 HEPES, 0.2 EGTA, 2 MgCl2, 2 NaATP, 0.5 NaGTP, 5 
phosphocreatine (osmolarity 305 mOsm, pH adjusted to 7.2 with CsOH). The AMPA receptor mediated 
component of the EPSC was estimated by measuring the peak amplitude of the averaged EPSC at −60 mV. 
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The NMDA receptor mediated component was estimated at +40 mV by measuring the amplitude of the 
averaged EPSC 25 ms after stimulation.  
For minimal stimulation, stimulation frequency was 0.2 Hz and the stimulation electrode was placed to 
produce a single-peak response. At +40 mV holding potential, stimulation intensity was reduced until 
transmission failures were observed (in ~ 10-40% of events), and 20-50 events were recorded. Cells were 
subsequently clamped to -60 mV holding potential, and 30-50 events were recorded at the same stimulation 
intensity. In a subset of experiments, this order was reversed, i.e. stimulation intensity was adjusted and 
miniature EPSCs (minEPSCs) were recorded at -60 mV first, before cells were clamped to +40 mV. We did 
not observe systematic differences in failure rates or amplitudes of minEPSCs between the two regimes. 
Experiments with linearly increasing or decreasing failure rates and/or minEPSC amplitudes at any holding 
potential were excluded from the analysis. Post-hoc analysis counted a failure at depolarized potentials 
whenever the EPSC charge 10 to 90 ms after stimulation did not exceed a fixed threshold of 0.15 pC. 
Failures at hyperpolarized potentials were defined as events with a minEPSC peak smaller than twice the 
signal noise of that recording (signal noise: standard deviation of the signal in a 3 ms time window averaged 
over all sweeps at a certain holding potential). Signal noise was not different between experimental groups, 
experiments with high background noise were excluded from the analysis. While the absolute failure rates 
depended on the criteria for failure vs successes were set, the relative difference between genotypes did not. 
Apparent synaptic potency was calculated as the EPSC amplitude of all events categorized as non-failures 
(at -60 mV by measuring the peak amplitude of the averaged EPSC, at +40 mV by measuring the amplitude 
25 ms after stimulation). The mean stimulation intensity used to evoke near-unitary events was not 
significantly different between genotypes (Student’s t-test: P = 0.967; +/+: 0.62 ± 0.29 V, n(N) = 10(5); –/–: 
0.65 ± 0.27 V, n(N) = 13(6)). 
For in vivo experiments, male 7-8 week old mice were implanted (under anesthesia) with a stimulation 
electrode in the Schaffer collaterals (2.0 mm posterior and 2.0 mm lateral to Bregma) and a recording 
electrode in the Stratum radiatum of the dorsal CA1 region (1.9 mm posterior and 1.4 mm lateral to Bregma), 
as described previously (Kemp and Manahan-Vaughan, 2008). Animals recovered for ~10 days before 
experiments were commenced. Before each experiment input/output (I/O) properties were recorded by 
increasing the stimulation intensity stepwise (Figure 2C). Experiments were carried out in recording 
chambers (20 (length) x 20 (width) x 30 (height) cm) where animals could move freely and had access to 
food and water ad libitum. During recordings, implanted electrodes were connected via a flexible cable and a 
rotatable commutator to the stimulation unit and amplifier. Test-pulse stimulation was set to elicit 40% of the 
maximal I/O response. Stimuli of 0.2 ms duration were applied at a frequency of 0.025 Hz and recorded with 
a sample rate of 10 kHz. To induce long-lasting LTP, two different induction protocols were used: Protocol 1 
contained 4 trains of 50 pulses at 100 Hz with 5 min inter train interval (N+/+ = 8, N–/– = 8). Protocol 2 
contained 2 trains of 50 pulses at 200 Hz with 5 min inter train interval (N+/+ = 8, N–/– = 7). Results from both 
protocols were quantitatively similar and pooled for Figure 2A. Short-lasting LTP was elicited using the 
following protocols: Protocol 3, a single train of 100 Hz stimulation (N+/+ = N–/– = 8), and Protocol 4, two trains 
of 100 Hz stimulation with 5 min inter train interval (N+/+ = N–/– = 8). Results from Protocol 3 and 4 were 
quantitatively similar and pooled for extended data Figure 2B. Statistical tests for expression of LTP within an 
experimental group involved comparing post-tetanus responses to pre-tetanus baseline with time as a 
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continuous and pre/post induction as a categorical variable. Tests between genotypes compared post-
induction time points only, with time as a continuous and genotype as a categorical variable. 
Analyses were performed using custom written procedures in IGOR Pro and MATLAB. Data in graphs and in 
the text are presented as mean ± standard error unless indicated otherwise. Unpaired two-tailed Student‘s t-
test (short: Student‘s t-test) and multiple way ANOVA were used to test for statistical significance. Results 
were considered significant at p < 0.05. Stimulus artifacts were blanked or cropped in sample traces. Sample 
sizes are given as number of experiments (n, applies to in vitro experiments only) and number of animals 
(N). 
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Figure 1. Enhanced LTP and reduced basal synaptic transmission in Shank2–/– mice in vitro 
A. Enhanced long-term potentiation in Shank2–/– mice in vitro. NMDA receptor dependent LTP in the CA1 
region of corticohippocampal slices was induced by high frequency stimulation protocol (‘HFS’, closed 
symbols). In a subset of experiments (+/+: 5/10, –/–: 7/9), synaptic responses of a non-potentiated fiber tract 
were recorded as an additional control (‘control’, open symbols). Example traces at top. **: p=0.0025 
(difference between genotypes in a two-way ANOVA; n(N)+/+ = 10(3), n(N)–/– = 9(3)). Slices were stored in an 
ACSF/oxygenized air interface chamber as reported by Won et al. (2012). B. Increased LTP in Shank2–/–
mice is irrespective of animal age and slice storage. Submerged data replotted from Schmeisser et al. 
(2012). Significance was tested with two-way ANOVA (***: p<0.0001 for genotype comparison across 
conditions; n(N)+/+ interface = 10(3), n(N)–/– interface = 9(3), n(N)+/+ submerged = 30(5), n(N)–/– submerged = 34(6)). C. 
Decreased basal synaptic transmission in Shank2–/– mice irrespective of animal age and slice storage. Basal 
transmission in each experiment is expressed as a single slope fitted to the input-output function of fEPSP 
slope versus fibre volley. Slopes of each group are normalized to the population mean slope of the wildtype 
in the respective recording condition. Submerged data (P25) and interface data (P90) are re-analyzed from 
Schmeisser et al. (2012). Significance was tested with two-way ANOVA (***: p=0.0005 for genotype 
comparison across conditions; n(N)+/+ interface P25 = 4(2), n(N)–/– interface P25 = 4(2), n(N)+/+ submerged P25 = 8(3), n(N)–
/– submerged P25 = 11(4), n(N)+/+ interface P90 = 9(3), n(N)–/– interface P90 = 9(3)). D. Slice storage conditions affect 
AMPA/NMDA receptor ratios. Significance was tested with Student’s t-test. AMPA/NMDA receptor ratios are 
significantly reduced in CA1 pyramidal cells of Shank2–/– mice when slices are stored submerged in ACSF 
(‘submerged 1’: p = 0.013 (*), data replotted from Schmeisser et al. (2012), n(N)+/+ = 18(8), n(N)–/– = 19(6); 
‘submerged 2’: p = 0.0012 (**), n(N)+/+ = 20(6), n(N)–/– = 18(8), see also Figure 3C), but not when stored in an 
ACSF/oxygenated air interface chamber (‘interface’: n(N)+/+ = 12(2), n(N)–/– = 12(2)). Mouse age was 3-4 
weeks for all groups. 
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Figure 2. Enhanced LTP and reduced basal synaptic transmission in Shank2–/– mice in vivo 
A. Enhanced long-term potentiation in Shank2–/– mice in vivo. NMDA receptor dependent LTP was induced 
by strong high frequency stimulation in awake, behaving mice (see Methods for details). Example traces at 
top. LTP was induced in both genotypes as tested by ANOVA (*: +/+: p<0.0001, N = 16; –/–: p=0.0125, N = 
15.) but was significantly larger in Shank2–/– mice (***: p<0.0001, difference between genotypes in a two-way 
ANOVA). B. NMDA receptor dependent LTP was induced by mild high frequency stimulation in awake, 
behaving mice (see Methods for details). Significance was tested with two-way ANOVA. LTP was induced in 
both genotypes (*; +/+: p<0.0001, N = 16; –/–: p=0.0125, N = 16) with no significant difference between 
genotypes. C. Basal synaptic transmission in awake, behaving mice is reduced in Shank2–/– mice compared 
to wildtype controls. *: p=0.011 (difference between genotypes in a two-way ANOVA; N+/+ = 12, N–/– = 8). 
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Figure 3. Minimal stimulation reveals insufficiently matured synapses in Shank2-/- mice 
A. EPSCs were recorded at different holding potentials under minimal stimulation in vitro. Failure rates 
indicate the proportion of AMPA receptor containing synapses (-60 mV) as a fraction of total synapses 
(+40 mV). Failure rates at different holding potentials are plotted for control (left) and Shank2–/– mice (right). 
**: p=0.0012 (paired Student’s t-test; n(N)+/+ = 11(6), n(N)–/– = 13(6)). Example traces at right (top panel: 
EPSPs recorded at +40 mV, bottom panel: EPSPs recorded at -60 mV). B. Synaptic potency as apparent in 
minimal stimulation experiments is not different between genotypes when differences in failure rates are 
taken into account, for both NMDA receptor mediated currents (+40 mV, left) and AMPA receptor mediated 
currents (-60 mV, right). Example traces at top. C. AMPA/NMDA receptor ratios calculated from average 
EPSP of minimal stimulation experiments are smaller in Shank2-/- mice than in wildtype controls. **: p=0.005 
(Student’s t-test; n(N)+/+ = 20(6), n(N)–/– = 18(8)). D. The relative difference between failure rates at 
hyperpolarized versus depolarized potentials (F-60 minus F+40) is significantly higher in Shank2-/- mice than in 
wildtype controls. **: p=0.0022 (Student’s t-test; n(N)+/+ = 11(6), n(N)–/– = 13(6)). 
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